1. Home
  2. ARVN vs STKL Comparison

ARVN vs STKL Comparison

Compare ARVN & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.96

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo SunOpta Inc.

STKL

SunOpta Inc.

SELL

Current Price

$6.50

Market Cap

768.2M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARVN
STKL
Founded
2015
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
768.2M
IPO Year
2018
1999

Fundamental Metrics

Financial Performance
Metric
ARVN
STKL
Price
$8.96
$6.50
Analyst Decision
Buy
Buy
Analyst Count
19
3
Target Price
$15.05
$7.50
AVG Volume (30 Days)
854.3K
855.4K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
186.67
EPS
N/A
0.13
Revenue
$262,600,000.00
$817,715,000.00
Revenue This Year
N/A
$6.84
Revenue Next Year
N/A
$33.58
P/E Ratio
N/A
$49.96
Revenue Growth
N/A
12.99
52 Week Low
$6.06
$3.32
52 Week High
$14.22
$6.94

Technical Indicators

Market Signals
Indicator
ARVN
STKL
Relative Strength Index (RSI) 35.45 64.45
Support Level $7.35 $6.43
Resistance Level $10.18 $6.51
Average True Range (ATR) 0.51 0.02
MACD -0.03 -0.01
Stochastic Oscillator 23.34 62.50

Price Performance

Historical Comparison
ARVN
STKL

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own proprietary brands, including SOWN, Dream, and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut, and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada, and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: